At Valuentum, we follow hundreds of stocks and dividends. We serve individual investors, financial advisers, and institutions. Join Today! You’ll gain immediate access to our premium product and service offering (including articles, commentary, stock reports, dividend reports, and more). You’ll also receive the Best Ideas Newsletter and Dividend Growth Newsletter in your inbox every month. You can also order our ultra-premium publications, the High Yield Dividend Newsletter and the Exclusive publication, too!

-
Phillips 66 Raises Dividend
Image Source: TradingView By Brian Nelson, CFA Phillips 66 (PSX) recently reported fourth quarter results that came in better than expected on the bottom line. Adjusted earnings were $1.0 billion or $2.47 per share in the quarter, while the company achieved record NGL transportation and fractional volumes of over 1 MMBD each. Phillips 66 delivered…
-
Enterprise Products Partners Posts Record Fourth Quarter
Image Source: TradingView By Brian Nelson, CFA Enterprise Products Partners (EPD) recently reported fourth quarter results that came in better than expected on both the top and bottom lines. In the fourth quarter, Enterprise reported net income attributable to common unitholders of $1.6 billion, similar to levels in the same period a year ago. On…
-
Dick’s Sporting Goods Raises Dividend
Image Source: TradingView By Brian Nelson, CFA Dick’s Sporting Goods (DKS) recently reported fourth quarter results that beat expectations on both the top and bottom lines. During the quarter, net sales increased 59.9% as it folded in its Foot Locker business, while consolidated non-GAAP earnings per diluted share came in at $3.45, down 5% from…
-
Valuentum’s Best Ideas Newsletter Portfolio
*Portfolio information as of published date in top, left corner of table above. The Best Ideas Newsletter portfolio is not a real money portfolio. Past results are not a guarantee of future performance, and actual results may differ from simulated information provided. There is substantial risk associated with investing in financial instruments. By The Valuentum…
-
Vertex’s Pipeline Continues to Advance
Image Source: TradingView By Brian Nelson, CFA Vertex Pharmaceuticals (VRTX) recently reported mixed fourth quarter 2025 results with revenue exceeding the consensus forecast, but non-GAAP earnings per share of $5.03 coming in a bit light relative to consensus. Total revenue increased 10% in the quarter, to $3.19 billion compared to the fourth quarter of 2024…




